FEMY Femasys Inc. - Common Stock
$3,10
Prix · Aoû 19, 2026
Données fondamentales au Aoû 14, 2026
Fourchette 52 semaines
$0–$8
38% of range
Note des analystes
BUY
9 analysts
Objectif de cours
$57
+1730% upside
P/E (TTM)
-0.3
ROE
-505.0%
Marge nette
-812.3%
FEMY Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.10
Capitalisation Boursière
$9M
P/E (TTM)
-0.3
BPA (TTM)
$-0.47
Revenus (TTM)
$2M
Rendement div.
—
ROE
-505.0%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $8
FEMY Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$2M
2020-12-31
→
2025-12-31
BPA
$-0.47
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-19M
2021-12-31
→
2025-12-31
Marges
-812.3%
2021-12-31
→
2022-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
FEMY
Médiane des pairs
P/E (TTM)
-0.3
27.5
P/S (TTM)
4.0
11.3
P/B
1.6
4.0
Price / FCF (Cours / FCF)
-0.5
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
FEMY
Médiane des pairs
Operating Margin (Marge d'exploitation)
-767.0%
—
Net Profit Margin (Marge nette)
-812.3%
-2016.2%
ROA
-112.3%
-116.3%
ROE
-505.0%
-195.7%
ROIC
-299.7%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
FEMY
Médiane des pairs
Current Ratio (Ratio de liquidité)
4.5
3.5
Quick Ratio (Ratio de liquidité réduite)
2.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
FEMY
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
40.8%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
23.9%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
17.2%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
FEMY
Médiane des pairs
FEMY Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
9 analystes
- Achat fort 2 22,2%
- Achat 6 66,7%
- Conserver 1 11,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
3 analystes · 2026-08-16
Médiane
$30.00
Moyenne
$56.67
← En dessous de tous les objectifs
$3.10
Bas
$10.00
Haut
$130.00
Objectif médian
$30.00
+868,8%
Objectif moyen
$56.67
+1730,0%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.58%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-1.20 | $-1.84 | 0.64% |
| 31 décembre 2025 | $-0.20 | $-1.78 | 1.6% |
| 30 septembre 2025 | $-2.00 | $-2.65 | 0.65% |
| 30 juin 2025 | $-3.00 | $-3.67 | 0.67% |
| 31 mars 2025 | $-0.23 | $-0.19 | -0.04% |
| 31 décembre 2024 | $-0.23 | $-0.19 | -0.04% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| FEMY | $34M | -1.2 | 40.8% | -812.3% | -505.0% | — |
| HSCS | — | — | — | — | — | — |
| NVNO | $210.6K | -0.0 | — | — | -64.7% | — |
| NXL | $11M | -1.1 | 78.8% | -2725.8% | -169.3% | 79.7% |
| INBS | $13M | -0.9 | -1.9% | -346.2% | -186.6% | 40.8% |
| AMIX | — | — | — | — | — | — |
| NDRA | $5M | -0.5 | — | — | -376.5% | — |
| BMRA | — | -1.4 | -1.9% | — | — | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $1M | $1M | $1M | $1M | |
| Cost of Revenue | $872.4K | $544.9K | $380.1K | $441.9K | $370.4K | $306.5K | |
| Gross Profit | · | · | · | $764.3K | $809.3K | $731.4K | |
| R&D Expense | $8M | $8M | $7M | $6M | $4M | $4M | |
| SG&A Expense | $7M | $6M | $7M | $5M | $4M | $3M | |
| Operating Expenses | $19M | $19M | $15M | $12M | $9M | $8M | |
| Operating Income | $-18M | $-18M | $-15M | $-12M | $-8M | $-7M | |
| Interest Expense | · | · | $165.4K | $13.5K | $19.2K | $12.6K | |
| Interest Income | $101.8K | $582.4K | $431.0K | · | · | · | |
| Other Non-op | $-482.6K | $0 | $265.6K | $212.4K | $803.0K | $20.0K | |
| Pretax Income | $-19M | $-19M | $-14M | $-11M | $-8M | $-7M | |
| Income Tax | $1.3K | $9.6K | $4.3K | $6.3K | $4.0K | $1.8K | |
| Net Income | $-19M | $-19M | $-14M | $-11M | $-8M | $-7M | |
| EPS (Basic) | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 | $-7.20 | |
| EPS (Diluted) | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 | $-7.20 | |
| Shares (Basic) | 39,549,218 | 22,267,695 | 15,384,376 | 11,815,019 | 6,712,028 | 959,862 | |
| Shares (Diluted) | 39,549,218 | 22,267,695 | 15,384,376 | 11,815,019 | 6,712,028 | 959,862 | |
| EBITDA | $-18M | $-18M | · | $-12M | $-8M | · |
Bilan 27
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $3M | $22M | $13M | $25M | $3M | |
| Receivables | $616.6K | $488.4K | $98.9K | $77.5K | $84.3K | $125.8K | |
| Inventory | $6M | $3M | $667.1K | $436.7K | $208.3K | $131.4K | |
| Other Current Assets | $833.1K | $1M | $695.9K | $655.4K | $555.9K | $284.1K | |
| Current Assets | $16M | $8M | $23M | $14M | $26M | $4M | |
| PP&E (Net) | $2M | $2M | $1M | $1M | $2M | $2M | |
| PP&E (Gross) | $6M | $5M | $5M | $5M | $4M | $4M | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $134.9K | $65.9K | $0 | $3.3K | $25.1K | $65.1K | |
| Other Non-current Assets | $940.2K | $955.0K | $1M | $958.2K | $655.4K | $792.4K | |
| Total Assets | $21M | $12M | $28M | $17M | $29M | $8M | |
| Accounts Payable | $2M | $1M | $1M | $510.8K | $445.5K | $674.3K | |
| Accrued Liabilities | $1M | $1M | $1M | $456.7K | $603.8K | $1M | |
| Short-term Debt | · | $0 | $0 | $141.3K | $181.1K | $630.0K | |
| Current Liabilities | $4M | $9M | $3M | $2M | $2M | $3M | |
| Capital Leases | $1M | $2M | $2M | $28.6K | $386.2K | $769.8K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $32.9K | |
| Total Liabilities | $15M | $10M | $9M | $2M | $2M | $4M | |
| Total Debt | · | · | · | $141.3K | $181.1K | · | |
| Common Stock | $3.0K | $23.5K | $21.8K | $12.0K | $11.9K | $1.1K | |
| Paid-in Capital | $147M | $128M | $124M | $109M | $108M | $23M | |
| Retained Earnings | $-146M | $-127M | $-108M | $-94M | $-83M | $-75M | |
| Treasury Stock | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | |
| AOCI | · | · | · | · | $0 | $0 | |
| Stockholders' Equity | $6M | $2M | $18M | $15M | $26M | $-52M | |
| Liabilities + Equity | $21M | $12M | $28M | $17M | $29M | $8M | |
| Shares Outstanding | 2,980,254 | 23,355,926 | 21,657,381 | 11,869,704 | 11,804,165 | 993,124 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $342.0K | $297.3K | $483.5K | $561.2K | $591.1K | $679.7K | |
| Stock-based Comp | $790.1K | $444.1K | $675.7K | $224.9K | $193.4K | $318.6K | |
| Deferred Tax | $-4M | $0 | $0 | $0 | $-2M | · | |
| Amort. of Intangibles | $46.2K | $20.1K | $3.3K | $21.8K | $40.0K | $118.9K | |
| Operating Cash Flow | $-19M | $-19M | $-11M | $-11M | $-8M | $-5M | |
| CapEx | $525.0K | $761.7K | $143.9K | $407.5K | $306.9K | $8.4K | |
| Investing Cash Flow | $-630.1K | $-847.8K | $-143.9K | $-407.5K | $-306.9K | $968.3K | |
| Stock Issued | · | $2M | $8M | $59.6K | $32M | $153.2K | |
| Stock Repurchased | · | $60.8K | $230.0K | $0 | · | · | |
| Net Stock Activity | · | $2M | · | $79.5K | $32M | · | |
| Financing Cash Flow | $25M | $2M | $20M | $-681.6K | $30M | $871.6K | |
| Taxes Paid | $6.8K | $5.7K | $4.5K | $5.0K | $800 | $2.0K | |
| Free Cash Flow | $-19M | $-20M | · | $-11M | $-8M | · | |
| Levered FCF | · | · | · | $-11M | $-8M | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 63.4% | 68.6% | · | |
| Operating Margin | -767.0% | -1091.8% | · | -961.7% | -706.7% | · | |
| Net Margin | -812.3% | -1155.0% | · | -944.6% | -639.0% | · | |
| Pretax Margin | -812.2% | -1154.4% | · | -944.1% | -638.6% | · | |
| EBITDA Margin | -767.0% | -1091.8% | · | -961.7% | -706.7% | · | |
| ROA | -112.3% | -93.6% | · | -50.1% | -41.7% | · | |
| ROE | -505.0% | -454.8% | · | -68.5% | -27.4% | · | |
| ROIC | -299.7% | -772.2% | · | -75.4% | -31.5% | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 0.9 | · | 9.2 | 15.1 | · | |
| Quick Ratio | 2.7 | 0.5 | · | 8.5 | 14.7 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | |
| Interest Coverage | · | · | · | -861.6 | -433.6 | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.2 | 0.3 | · | 1.4 | 2.2 | · | |
| Receivables Turnover | 4.2 | 5.5 | · | 14.9 | 11.2 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 40.8% | 52.0% | -11.1% | 2.2% | 13.7% | · | |
| Revenue CAGR 3Y | 23.9% | 11.4% | 1.1% | · | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $1M | $1M | $1M | · | |
| Net Income TTM | $-19M | $-19M | $-14M | $-11M | $-8M | · | |
| Market Cap | $34M | $26M | · | $11M | $46M | · | |
| Enterprise Value | · | · | · | $-2M | $21M | · | |
| P/E | -1.2 | -1.3 | -1.0 | -0.9 | -3.5 | · | |
| P/S | 15.0 | 15.8 | · | 8.9 | 39.0 | · | |
| P/B | 5.8 | 11.1 | · | 0.7 | 1.7 | · | |
| P / Tangible Book | 6.0 | 11.5 | 1.2 | 0.7 | 1.7 | · | |
| P / Cash Flow | -1.8 | -1.3 | · | -1.0 | -5.8 | · | |
| P / FCF | -1.8 | -1.3 | · | -1.0 | -5.6 | · | |
| EV / EBITDA | · | · | · | 0.2 | -2.6 | · | |
| EV / FCF | · | · | · | 0.2 | -2.6 | · | |
| EV / Revenue | · | · | · | -1.8 | 18.2 | · | |
| Earnings Yield | -81.6% | -77.3% | -95.4% | -106.7% | -28.7% | · |
Compte de résultat 18
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $331.8K | $424.9K | $813.4K | $729.4K | $409.3K | $341.3K | $581.6K | $554.9K | $221.5K | $271.1K | $213.1K | $244.4K | $320.5K | $294.0K | $234.2K | $347.5K | |
| Cost of Revenue | $142.4K | $158.6K | $303.1K | $293.8K | $158.2K | $117.3K | $192.4K | $190.8K | $73.1K | $88.5K | $78.3K | $86.2K | $110.5K | $105.1K | $85.5K | $131.5K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $158.2K | $210.0K | $188.9K | · | $216.0K | |
| R&D Expense | $2M | $1M | $2M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | |
| Operating Expenses | $5M | $4M | $5M | $4M | $4M | $6M | $5M | $5M | $5M | $4M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Operating Income | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-5M | $-4M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $361.6K | · | $8.0K | $198 | $1.7K | $3.8K | $6.0K | |
| Interest Income | $19.7K | $49.8K | $48.3K | $17.3K | $17.1K | $19.0K | $49.5K | $124.0K | $184.1K | $224.7K | $198.9K | $92.4K | $42.7K | · | · | · | |
| Other Non-op | $0 | $5M | $244.2K | $-26.3K | $-260.0K | $-440.4K | $136.9K | $0 | $0 | $-136.9K | $43.4K | $84.4K | $42.5K | $95.4K | $112.5K | $74.3K | |
| Pretax Income | $-4M | $846.1K | $-4M | $-4M | $-5M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-4M | $-3M | · | · | · | |
| Income Tax | $865 | $0 | $5.5K | $0 | $0 | $-4.2K | $10.2K | $1.2K | $-1.8K | $0 | $4.3K | $0 | $0 | · | · | · | |
| Net Income | $-4M | $846.1K | $-4M | $-4M | $-5M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-1.33 | $0.00 | $0.02 | $-0.10 | $-3.18 | $-0.23 | $-0.23 | $-0.24 | $-0.21 | $-0.17 | $-0.20 | $-0.26 | $-0.22 | $-0.25 | $-0.25 | $-0.25 | |
| EPS (Diluted) | $-1.33 | $0.00 | $0.02 | $-0.10 | $-3.18 | $-0.23 | $-0.23 | $-0.24 | $-0.21 | $-0.17 | $-0.20 | $-0.26 | $-0.22 | $-0.25 | $-0.25 | $-0.25 | |
| Shares (Basic) | 3,357,117 | 66,645,591 | -55,495,918 | 41,015,196 | 1,444,036 | 25,149,236 | -43,955,977 | 22,232,799 | 22,215,516 | 21,775,357 | -24,688,616 | 15,093,147 | 13,107,590 | 11,872,255 | -23,615,744 | 11,813,610 | |
| Shares (Diluted) | 3,357,117 | 78,095,633 | -55,495,918 | 41,015,196 | 1,444,036 | 25,149,236 | -43,955,977 | 22,232,799 | 22,215,516 | 21,775,357 | -24,688,616 | 15,093,147 | 13,107,590 | 11,872,255 | -23,615,744 | 11,813,610 | |
| EBITDA | $-5M | $-4M | · | $-4M | $-4M | $-5M | · | $-5M | $-4M | $-3M | · | $-4M | $-3M | $-3M | · | $-3M |
Bilan 25
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $5M | $9M | $5M | $3M | $4M | $3M | $8M | $14M | $18M | $22M | $9M | $11M | $10M | $13M | $16M | |
| Receivables | $151.0K | $172.3K | $616.6K | $572.2K | $254.6K | $233.6K | $488.4K | $378.3K | $92.5K | $120.5K | $98.9K | $103.6K | $155.7K | $124.0K | $77.5K | $183.1K | |
| Inventory | $6M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $1M | $971.3K | $667.1K | $602.7K | $581.5K | $500.7K | $436.7K | $343.1K | |
| Other Current Assets | $546.1K | $679.9K | $833.1K | $1M | $1M | $1M | $1M | $1M | $997.6K | $955.5K | $695.9K | $826.4K | $587.8K | $542.1K | $655.4K | $760.6K | |
| Current Assets | $8M | $12M | $16M | $12M | $10M | $9M | $8M | $11M | $16M | $20M | $23M | $10M | $12M | $11M | $14M | $17M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | |
| Intangibles | $115.5K | $124.3K | $134.9K | $130.0K | $55.6K | $58.7K | $65.9K | $70.1K | $44.3K | $33.1K | $0 | $388 | $970 | $1.9K | $3.3K | $5.8K | |
| Other Non-current Assets | $918.6K | $924.6K | $940.2K | $744.8K | $829.2K | $838.0K | $955.0K | $887.4K | $957.1K | $1M | $1M | $937.0K | $865.6K | $920.8K | $958.2K | $789.6K | |
| Total Assets | $12M | $16M | $21M | $16M | $14M | $13M | $12M | $16M | $20M | $24M | $28M | $15M | $14M | $14M | $17M | $20M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $1M | $951.5K | $1M | $1M | $851.9K | $546.9K | $526.8K | $510.8K | $419.1K | |
| Accrued Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $886.4K | $673.5K | $1M | $569.4K | $536.8K | $535.4K | $456.7K | $649.6K | |
| Short-term Debt | · | · | · | $276.5K | · | · | · | · | · | · | · | $283.3K | $0 | $0 | $141.3K | $280.6K | |
| Current Liabilities | $4M | $3M | $4M | $11M | $11M | $10M | $9M | $3M | $2M | $2M | $3M | $2M | $1M | $1M | $2M | $2M | |
| Capital Leases | $796.0K | $912.5K | $1M | $1M | $1M | $1M | $2M | · | · | · | $2M | · | · | · | $28.6K | · | |
| Total Liabilities | $8M | $9M | $15M | $12M | $12M | $11M | $10M | $10M | $9M | $9M | $9M | $4M | $1M | $2M | $2M | $2M | |
| Total Debt | · | · | · | $276.5K | · | · | · | · | · | · | · | $283.3K | $0 | $0 | · | $280.6K | |
| Common Stock | $3.0K | $60.5K | $59.7K | $47.4K | $32.7K | $27.2K | $23.5K | $22.4K | $22.4K | $22.2K | $21.8K | $16.1K | $15.2K | $12.0K | $12.0K | $11.9K | |
| Paid-in Capital | $148M | $147M | $146M | $140M | $137M | $133M | $128M | $125M | $125M | $125M | $124M | $113M | $111M | $109M | $109M | $109M | |
| Retained Earnings | $-149M | $-145M | $-146M | $-142M | $-138M | $-133M | $-127M | $-122M | $-117M | $-112M | $-108M | $-104M | $-100M | $-97M | $-94M | $-91M | |
| Treasury Stock | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | |
| Stockholders' Equity | $4M | $7M | $6M | $5M | $2M | $2M | $2M | $6M | $11M | $16M | $18M | $10M | $13M | $12M | $15M | $18M | |
| Liabilities + Equity | $12M | $16M | $21M | $16M | $14M | $13M | $12M | $16M | $20M | $24M | $28M | $15M | $14M | $14M | $17M | $20M | |
| Shares Outstanding | 3,023,967 | 60,390,686 | 59,602,787 | 47,302,373 | 32,575,407 | 27,087,886 | 23,355,926 | 22,232,799 | 22,232,799 | 22,099,347 | 21,657,381 | 15,992,869 | 15,073,153 | 11,872,573 | 11,869,704 | 11,813,610 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $82.8K | $82.3K | $85.2K | $85.7K | $86.3K | $84.9K | $82.2K | $76.3K | $67.6K | $71.2K | $91.8K | $125.3K | $133.3K | $133.1K | $134.8K | $139.6K | |
| Stock-based Comp | $210.8K | $151.6K | $66.4K | $174.5K | $182.0K | $367.2K | $134.1K | $128.4K | $104.0K | $77.6K | $49.2K | $504.4K | $65.2K | $57.0K | $66.7K | $51.8K | |
| Amort. of Intangibles | $19.0K | $16.7K | $16.7K | $13.7K | $8.6K | $7.2K | $8.0K | $6.3K | $4.6K | $1.2K | $388 | $581 | $912 | $1.4K | $2.5K | $4.8K | |
| Operating Cash Flow | $-4M | $-4M | $-4M | $-5M | $-4M | $-5M | $-5M | $-5M | $-4M | $-5M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| CapEx | $9.4K | $79.1K | $139.8K | $194.3K | $94.2K | $96.6K | $106.8K | $407.9K | $182.4K | $64.6K | $44.9K | $27.2K | $62.9K | $8.9K | $93.9K | $18.5K | |
| Investing Cash Flow | $-22.2K | $-79.1K | $-196.7K | $-239.8K | $-97.0K | $-96.6K | $-110.6K | $-440.0K | $-207.0K | $-90.2K | $-44.9K | $-27.2K | $-62.9K | $-8.9K | $-93.9K | $-18.5K | |
| Stock Issued | · | · | · | · | $-882.0K | $5M | · | $-8M | $-802.2K | $802.2K | $8M | $0 | $0 | $3.4K | $59.6K | $-16.2K | |
| Stock Repurchased | · | · | · | · | · | $161.8K | · | $0 | $6.6K | $24.1K | $230.0K | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $5M | · | · | · | $778.2K | · | · | · | $3.4K | · | · | |
| Financing Cash Flow | $15.3K | $342.3K | $9M | $7M | $4M | $5M | $1M | $0 | $223.5K | $778.2K | $16M | $870.3K | $3M | $-144.1K | $-82.0K | $-362.0K | |
| Taxes Paid | $-5.5K | $0 | $800 | $0 | $6.0K | $0 | $0 | $1.2K | · | · | $0 | $4.5K | $0 | $0 | $0 | $4.2K | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-5M | · | · | · | $-3M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 64.7% | 65.5% | 64.2% | · | 62.2% | |
| Operating Margin | -1526.7% | -994.0% | · | -500.9% | -941.1% | -1600.1% | · | -922.4% | -2023.7% | -1277.1% | · | -1670.2% | -916.0% | -1034.6% | · | -879.9% | |
| Net Margin | -1346.8% | 199.1% | · | -575.1% | -1120.5% | -1727.9% | · | -974.7% | -2115.1% | -1327.5% | · | -1635.7% | -902.8% | -1002.2% | · | -858.5% | |
| Pretax Margin | -1346.5% | 199.1% | · | -575.1% | -1120.5% | -1729.2% | · | -974.5% | -2115.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -1526.7% | -994.0% | · | -500.9% | -941.1% | -1600.1% | · | -922.4% | -2023.7% | -1277.1% | · | -1670.2% | -916.0% | -1034.6% | · | -879.9% | |
| ROA | -34.3% | 5.7% | · | -26.3% | -26.9% | -31.3% | · | -35.5% | -27.1% | -18.8% | · | -22.9% | -15.5% | -15.0% | · | -11.7% | |
| ROE | -161.4% | 18.2% | · | -79.7% | -71.9% | -67.0% | · | -65.9% | -38.8% | -25.7% | · | -28.1% | -17.1% | -16.4% | · | -12.8% | |
| ROIC | -125.7% | -57.9% | · | -75.6% | -255.5% | -273.3% | · | -85.8% | -39.8% | · | · | · | · | · | · | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 3.9 | · | 1.2 | 0.9 | 0.9 | · | 3.9 | 6.5 | 8.4 | · | 4.7 | 8.7 | 8.0 | · | 9.6 | |
| Quick Ratio | 0.4 | 1.8 | · | 0.5 | 0.3 | 0.4 | · | 2.8 | 5.5 | 7.6 | · | 4.0 | 7.9 | 7.3 | · | 9.0 | |
| Debt / Equity | · | · | · | 0.1 | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.6 | · | -508.1 | -14828.1 | -1819.2 | · | -509.1 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | 0.3 | · | 0.5 | |
| Receivables Turnover | 1.6 | 2.1 | · | 1.5 | 2.4 | 1.9 | · | 2.3 | 1.8 | 2.2 | · | 1.7 | 2.4 | 2.0 | · | 2.1 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Net Income TTM | $-12M | $-14M | · | $-20M | $-21M | $-20M | · | $-18M | $-15M | $-13M | · | $-13M | $-11M | $-11M | · | $-11M | |
| Market Cap | $13M | $25M | · | $17M | $31M | $34M | · | $25M | $25M | $34M | · | $48M | $8M | $13M | · | $13M | |
| Enterprise Value | · | · | · | $12M | · | · | · | · | · | · | · | $39M | $-3M | $3M | · | $-2M | |
| P/E | -0.9 | -0.9 | · | -0.5 | -1.1 | -1.5 | · | -1.3 | -1.3 | -1.7 | · | -3.0 | -0.5 | -1.1 | · | -1.3 | |
| P/S | 6.7 | 13.3 | · | 8.2 | 20.6 | 24.4 | · | 19.1 | 24.0 | 30.3 | · | 39.5 | 6.1 | 10.2 | · | 10.8 | |
| P/B | 3.1 | 3.5 | · | 3.7 | 20.9 | 17.0 | · | 4.1 | 2.3 | 2.2 | · | 4.6 | 0.6 | 1.0 | · | 0.7 | |
| P / Tangible Book | 3.2 | 3.5 | · | 3.8 | 21.7 | 17.5 | · | 4.2 | 2.3 | 2.2 | · | 4.6 | 0.6 | 1.0 | · | 0.7 | |
| P / Cash Flow | · | -6.1 | · | · | · | -7.1 | · | · | · | -7.5 | · | · | · | -4.9 | · | · | |
| P / FCF | · | -6.0 | · | · | · | -7.0 | · | · | · | -7.4 | · | · | · | -4.8 | · | · | |
| EV / EBITDA | · | · | · | -3.4 | · | · | · | · | · | · | · | -9.6 | 1.0 | -0.9 | · | 0.8 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.0 | · | · | |
| EV / Revenue | · | · | · | 6.1 | · | · | · | · | · | · | · | 32.5 | -2.4 | 2.1 | · | -1.9 | |
| Earnings Yield | -110.3% | -116.7% | · | -207.4% | -87.0% | -68.0% | · | -79.3% | -75.4% | -58.1% | · | -32.9% | -184.3% | -88.5% | · | -79.7% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $2M | $2M | $1M | $1M | $1M |
| Marge Brute % | — | — | — | 63.4% | 68.6% |
| Marge d'exploitation % | -767.0% | -1091.8% | — | -961.7% | -706.7% |
| Résultat net | $-19M | $-19M | $-14M | $-11M | $-8M |
| BPA dilué | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | — | — | 0.0 | 0.0 |
| Ratio de liquidité | 4.5 | 0.9 | — | 9.2 | 15.1 |
| Ratio de liquidité réduite | 2.7 | 0.5 | — | 8.5 | 14.7 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-19M | $-20M | — | $-11M | $-8M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 4 déclarants · $680K total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 0 | 33 | 0 | 1 | — |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée. Variation par rapport au trimestre précédent non affichée : la couverture des déclarants diffère trop entre ces deux trimestres pour une comparaison fiable.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $671 431 | 1 165 679 | 98,68% | Actions |
| Pandora Wealth, Inc. | $8 643 | 15 000 | 1,27% | Actions |
| IFP Advisors, Inc | $306 | 1 000 | 0,04% | Actions |
| CX Institutional | $3 | 750 | 0,00% | Actions |
Initiés de la société 20 initiés · 4 dirigeants · 7 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel Scott Currie | Chief Operating Officer | 2 juin 2025 I | 86 275 | 0 | 0 | $0 |
| Kelley Stinson Nicholas | Chief Commercial Officer | 23 juin 2025 A | — | 0 | 0 | $0 |
| Christine E Thomas | Chief Reg & Clinical Officer | 28 janvier 2025 A | — | 0 | 0 | $0 |
| Richard D. Spector | Chief Commercial Officer | 12 février 2024 A | — | 0 | 0 | $0 |
| Joshua Silverman | Administrateur | 25 juin 2025 A | — | 0 | 0 | $0 |
| Anne Morrissey | Administrateur | 21 juin 2023 A | — | 0 | 0 | $0 |
| Wendy Perrow | Administrateur | 21 juin 2023 A | — | 0 | 0 | $0 |
| Keith J Kendall | Administrateur | 14 juin 2023 A | — | 0 | 0 | $0 |
| John Q Adams JR | Administrateur | 8 juin 2022 A | 239 938 | 0 | 0 | $0 |
| John Dyett | Administrateur | 8 juin 2022 A | 114 709 | 0 | 0 | $0 |
| William Benson Witte | Administrateur | 15 décembre 2021 J | 12 191 | 0 | 0 | $0 |
| Jeffrey Gerald Mifek | — | 7 août 2026 A | 3 125 | 1 | 0 | $10 000 |
| John Charles Canning | — | 7 août 2026 A | 4 375 | 1 | 0 | $14 000 |
| Jeremy Alexander Sipos | — | 7 août 2026 A | 3 125 | 1 | 0 | $10 000 |
| Kathy Lee-Sepsick | — | 7 août 2026 A | 15 625 | 1 | 0 | $50 000 |
| Dov Elefant | — | 7 août 2026 A | 15 625 | 1 | 0 | $50 000 |
| Kenneth D. Eichenbaum | — | 24 juin 2026 A | — | 0 | 0 | $0 |
| Alistair Milnes | — | 24 juin 2026 A | — | 0 | 0 | $0 |
| Charles Larsen | — | 24 juin 2026 A | 56 | 0 | 0 | $0 |
| Edward R Uzialko | — | 24 juin 2026 A | 30 175 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Nantahala Capital Partners Limited Partnership, Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack | 17 août 2026 | 9,99% | Dépôt initial | Investissement passif | SEC |
| PharmaCyte Biotech, Inc. | 22 novembre 2023 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 2 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.